Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VITdAL-PICU: Vitamin D Normalization in Critically Ill Children
NCT02452762Phase 2Completed
- Sponsor
- Children's Hospital of Eastern Ontario
- Start
- Jan 2016
- Primary completion
- Nov 2017
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 3
01
Overview
Phase 2, randomised, double-blind trial of vitamin d in Vitamin D deficiency (VDD) (2 arms), sponsored by Children's Hospital of Eastern Ontario. Primary endpoint: Blood Vitamin D Levels at 7 days. Started Jan 2016; status: completed.
02
Drugs
vitamin d
03
Conditions
Vitamin D deficiency (VDD)
Beyond the preview
Go deeper on NCT02452762.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02452762.